Regulation of transcription and tumor suppression by MTG family members
Regulation of transcription and tumor suppression by MTG family members
批准号:
8696545
负责人:
SCOTT W HIEBERT
金额:
$36.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-13 至 2019-04-30
关键词:
Acute Myelocytic LeukemiaAddressAffectAtlasesBindingC-terminalCBFA2T1 geneChimeric ProteinsChromatinChromosomal translocationChromosomes, Human, Pair 16Chromosomes, Human, Pair 8Colon CarcinomaComplexDNA BindingDNA Binding DomainDNA MethylationDNA Polymerase IIDataDevelopmentE proteinElongation FactorEnzymesEventFamily memberGene ActivationGene ExpressionGene FamilyGene ProteinsGenesGeneticGenetic TranscriptionGenomeHistonesHodgkin DiseaseLengthLinkMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of ovaryModelingMusMutateMutationMyelogenousN-terminalNCOR1 geneNCOR2 genePhenotypePhysiologicalPoint MutationProteomicsRNARNA SplicingRUNX1 geneRecruitment ActivityRegulationRoleRunningSolid NeoplasmTAL1 geneTCF3 geneTCF7L2 geneTestingThe Cancer Genome AtlasTranscription ElongationTranscriptional Elongation FactorsTranscriptional RegulationTumor SuppressionVariantWorkYeastsgene repressionhistone methyltransferasein vivoinnovationleukemiamalignant breast neoplasmmouse modelmutantnovelnovel strategiespublic health relevancerelease factorresearch studyt(821)(q22q22)transcription factortranscriptional intermediary factor 1tumortumorigenesisyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Two myeloid translocation gene (MTG) family members, MTG8 and MTG16 are disrupted by chromosomal translocations in acute myeloid leukemia. In addition, the caner genome atlas (TCGA) and other large sequencing studies have identified mutations in MTG family members that are scattered throughout the gene body, suggesting that these may be inactivating mutations. Consistent with this interpretation, MTG16 is affected by DNA methylation in Hodgkin's lymphoma and MTG16 and MTGR1 are under expressed in colon cancer. Our preliminary data support this hypothesis in that inactivating mutations accelerated tumorigenesis in three separate mouse models of cancer. Mechanistically, MTG family members have been tangentially linked to transcriptional control at the level of RNA Pol II pausing and elongation through associations with CDK9 and Tif1 (or "Moonshine"). Our preliminary data shows that MTG family members make direct contacts with key regulators of the transcriptional elongation machinery to negatively regulate gene expression. Importantly, cancer associated mutations of MTG family members affect these contacts with elongation factors. Thus, we hypothesize that MTG-dependent regulation of transcriptional pausing/elongation is a key event in tumor suppression and that release of this negative regulation allows activation of genes controlled by transcriptional pausing. By defining the mechanism by which MTGs regulate transcriptional elongation using genetics and innovative new approaches such as global run on transcription sequencing, and by using mouse models of tumorigenesis, we will directly test this hypothesis and define how loss of transcriptional control at the level of pausing and elongation contributes to tumor development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
-
批准号:10445091
-
项目类别:
-
资助金额:$42.29万
-
财政年份:2021
-
负责人:SCOTT W HIEBERT
-
依托单位:
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
-
批准号:10298288
-
项目类别:
-
资助金额:$45.72万
-
财政年份:2021
-
负责人:SCOTT W HIEBERT
-
依托单位:
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
-
批准号:10652591
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2021
-
负责人:SCOTT W HIEBERT
-
依托单位:
Regulation of transcription and tumor suppression by MTG family members
-
批准号:9265416
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2014
-
负责人:SCOTT W HIEBERT
-
依托单位:
Regulation of transcription and tumor suppression by MTG family members
-
批准号:9055662
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2014
-
负责人:SCOTT W HIEBERT
-
依托单位:
FASEB SRC on HDACs, Sirtuins and Reversible Acetylation in Signaling and Disease
-
批准号:8595760
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2013
-
负责人:SCOTT W HIEBERT
-
依托单位:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
-
批准号:8607465
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2012
-
负责人:SCOTT W HIEBERT
-
依托单位:
Establishing that Hdac3 is a therapeutic target in a subset of B cell Lymphoma
-
批准号:9924498
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2012
-
负责人:SCOTT W HIEBERT
-
依托单位:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
-
批准号:8230922
-
项目类别:
-
资助金额:$40.45万
-
财政年份:2012
-
负责人:SCOTT W HIEBERT
-
依托单位:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
-
批准号:8431792
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2012
-
负责人:SCOTT W HIEBERT
-
依托单位:
Establishing that Hdac3 is a therapeutic target in a subset of B cell Lymphoma
-
批准号:10162514
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2012
-
负责人:SCOTT W HIEBERT
-
依托单位:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
-
批准号:8791883
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2012
-
负责人:SCOTT W HIEBERT
-
依托单位:
Establishing that Hdac3 is a therapeutic target in a subset of B cell Lymphoma
-
批准号:10406170
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2012
-
负责人:SCOTT W HIEBERT
-
依托单位:
Inactivation of Hdac3 in the cause, prevention, and treatment of HCC
-
批准号:8447369
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2010
-
负责人:SCOTT W HIEBERT
-
依托单位:
Inactivation of Hdac3 in the cause, prevention, and treatment of HCC
-
批准号:7889851
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2010
-
负责人:SCOTT W HIEBERT
-
依托单位:
Inactivation of Hdac3 in the cause, prevention, and treatment of HCC
-
批准号:8068821
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2010
-
负责人:SCOTT W HIEBERT
-
依托单位:
Inactivation of Hdac3 in the cause, prevention, and treatment of HCC
-
批准号:8217259
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2010
-
负责人:SCOTT W HIEBERT
-
依托单位:
Inactivation of Hdac3 in the cause, prevention, and treatment of HCC
-
批准号:8615915
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2010
-
负责人:SCOTT W HIEBERT
-
依托单位:
Function of MTG16/ETO2 in acute leukemia
-
批准号:7798492
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2007
-
负责人:SCOTT W HIEBERT
-
依托单位:
Function of MTG16/ETO2 in acute leukemia
-
批准号:7393198
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2007
-
负责人:SCOTT W HIEBERT
-
依托单位:
海外基金